US · CTEV
Claritev Corporation
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- New York City, NY 10003
- Website
- claritev.com
Price · as of 2025-12-31
$24.93
Market cap 222.6M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $168.52 | +575.97% |
| Intrinsic Value(DCF) | $5.77 | -76.86% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $246.80 | $758.93 | $0.00 | $0.00 | $0.00 |
| 2021 | $196.00 | $386.95 | $0.00 | $0.00 | $166.18 |
| 2022 | $42.80 | $222.81 | $0.00 | $0.00 | $0.00 |
| 2023 | $36.08 | $270.70 | $13.31 | $0.00 | $13.60 |
| 2024 | $18.26 | $97.73 | $0.00 | $0.00 | $0.00 |
| 2025 | $14.43 | $168.52 | $0.00 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Claritev Corporation's (CTEV) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $168.52
- Current price
- $24.93
- AI upside
- +575.97%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$5.77
-76.86% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| CTEV | Claritev Corporation | $24.93 | 222.6M | +576% | -77% | — | — | -0.83 | -1.36 | 0.25 | 10.21 | — | -0.05 | 27.61% | 4.67% | -29.45% | 632.60% | 0.76% | -5.66% | -26.64 | 0.11 | 0.86 | 0.59 | 9.71 | -8303.00% | 374.00% | 1685.00% | -5.18% | 0.45 | -0.27% | 0.00% | 0.00% | 0.00% | 107.70 | -395.26 | 5.03 | -0.45 |
| AXGN | AxoGen, Inc. | $31.73 | 1.59B | +57% | -27% | -97% | — | -89.88 | 10.95 | 6.27 | 7266.33 | -187.94 | 11.56 | 74.31% | -3.49% | -6.97% | -13.49% | -6.24% | -7.38% | 0.15 | -1.02 | 5.11 | 2.62 | -84.93 | 4783.00% | 2021.00% | -2676364.00% | -0.21% | 0.03 | -2.33% | 0.00% | 0.00% | 4.07% | -177.75 | -475.67 | 6.19 | 8.61 |
| DNTH | Dianthus Therapeutics, In… | $55.19 | 2B | -29% | -75% | — | — | -9.42 | 2.27 | 128.39 | -5.19 | — | 2.27 | 100.00% | -1633.74% | -1362.77% | -32.60% | -273.59% | -30.71% | 0.00 | — | 15.22 | 14.96 | 0.21 | -6982.00% | 12063.00% | 11175.00% | -9.78% | -4.24 | -210.26% | 0.00% | 0.00% | 0.00% | -5.17 | -6.73 | 84.49 | 21.62 |
| EVH | Evolent Health, Inc. | $3.25 | 376.91M | +378% | -56% | — | +2,393% | -0.71 | 0.98 | 0.22 | -0.76 | -0.13 | -0.47 | 15.09% | -0.24% | -28.49% | -81.81% | -0.48% | -26.08% | 0.05 | -0.08 | 1.31 | 1.23 | 0.37 | 52593.00% | -2656.00% | -17759.00% | 1.16% | 0.10 | 0.52% | 2.72% | -1.90% | 194.02% | -62.28 | 58.08 | 0.15 | 0.25 |
| GDRX | GoodRx Holdings, Inc. | $1.87 | 635.85M | +1,396% | -39% | -10% | +8% | 30.91 | 1.25 | 0.97 | 3.10 | 29.70 | 6.35 | 92.77% | 10.98% | 10.37% | 3.73% | 14.18% | 1.79% | 0.10 | 2.05 | 2.61 | 2.02 | -1.10 | 10407.00% | 57.00% | -3234.00% | 9.94% | 0.55 | 12.45% | 0.00% | 0.00% | 65.21% | 6.53 | 7.43 | 0.72 | 0.29 |
| IART | Integra LifeSciences Hold… | $11.38 | 886.41M | +457% | -63% | — | — | -1.55 | 0.77 | 0.49 | -1.58 | -0.02 | -1.13 | 51.69% | -30.17% | -31.58% | -39.90% | -21.27% | -13.52% | 0.21 | -5.72 | 2.54 | 1.19 | 0.04 | 736120.00% | 153.00% | -22439.00% | -3.88% | 0.11 | -1.46% | 0.00% | 0.00% | 219.53% | -1.53 | -24.24 | 0.46 | 0.59 |
| INMD | InMode Ltd. | $13.75 | 871.18M | +312% | -24% | +30% | -77% | 9.40 | 1.29 | 2.38 | 3.06 | — | 1.29 | 78.54% | 23.05% | 25.33% | 13.53% | 56.67% | 12.09% | 0.02 | — | 9.88 | 8.55 | -2.61 | -3644.00% | -616.00% | -3615.00% | 9.56% | 1.21 | 65.78% | 0.00% | 0.00% | 30.54% | 3.98 | 4.03 | 0.92 | 9.96 |
| IRMD | IRadimed Corporation | $103.53 | 1.32B | -46% | -36% | — | -72% | 33.89 | 7.51 | 8.90 | 26.33 | 305.02 | 7.79 | 76.94% | 29.99% | 26.26% | 24.31% | 59.56% | 20.20% | 0.00 | — | 8.84 | 7.38 | -2.29 | 1111.00% | 1171.00% | 22283.00% | 2.70% | 3.01 | 60.30% | 2.10% | 71.10% | 2.77% | 27.31 | 34.04 | 8.19 | 37.09 |
| LFMD | LifeMD, Inc. | $2.67 | 128.52M | +1,008% | +2,300% | — | — | -10.27 | -35.07 | 0.91 | -27.43 | — | -9.02 | 88.67% | -7.60% | -8.89% | 1891.64% | 123.73% | -28.61% | -4.58 | -7.40 | 0.81 | 0.72 | 1.49 | -2429.00% | 3927.00% | 677408.00% | 3.11% | 0.29 | -45.81% | 1.61% | -16.60% | 1.61% | -11.30 | 30.53 | 0.86 | -1.05 |
| OPK | OPKO Health, Inc. | $1.20 | 921.24M | +2,047% | -57% | — | +48% | -4.21 | 0.75 | 1.56 | -20.44 | -1.44 | 3.55 | 61.01% | -36.08% | -37.20% | -17.14% | -14.89% | -10.92% | 0.33 | -2.16 | 3.97 | 3.13 | -0.89 | 29113.00% | -1490.00% | -848.00% | -20.10% | -1.22 | -13.88% | 0.00% | 0.00% | 3.09% | -4.53 | -5.20 | 1.64 | -0.35 |
| SANA | Sana Biotechnology, Inc. | $4.21 | 1.12B | — | — | — | — | -2.23 | 2.38 | — | -2.10 | — | 11.75 | 0.00% | — | — | -99.17% | -144.07% | -50.03% | 0.38 | — | 3.54 | 3.36 | 0.13 | -2055.00% | — | -622.00% | -43.07% | -4.91 | -135.54% | 0.00% | 0.00% | 0.66% | -1.97 | -2.09 | — | -4.58 |
About Claritev Corporation
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.
- CEO
- Travis S. Dalton
- Employees
- 2.7K
- Beta
- 0.53
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($5.77 ÷ $24.93) − 1 = -76.86% (DCF, example).